Ignite Creation Date:
2025-12-24 @ 9:22 PM
Ignite Modification Date:
2025-12-31 @ 9:14 PM
Study NCT ID:
NCT01482104
Status:
COMPLETED
Last Update Posted:
2017-10-27
First Post:
2011-11-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC)
Sponsor:
Norwegian University of Science and Technology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-06
Start Date Type:
ACTUAL
Primary Completion Date:
2017-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-10
Completion Date Type:
ACTUAL
First Submit Date:
2011-11-17
First Submit QC Date:
None
Study First Post Date:
2011-11-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-10-26
Last Update Post Date:
2017-10-27
Last Update Post Date Type:
ACTUAL